> top > docs > PubMed:33152616 > spans > 500-693 > annotations

PubMed:33152616 / 500-693 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T4 0-193 Sentence denotes Several drugs such as antimalarial, antibiotic, anti-inflammatory and HIV-protease inhibitors are currently undergoing treatment as clinical studies to test the efficacy and safety of COVID-19.
T4 0-193 Sentence denotes Several drugs such as antimalarial, antibiotic, anti-inflammatory and HIV-protease inhibitors are currently undergoing treatment as clinical studies to test the efficacy and safety of COVID-19.

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T6 70-73 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 184-192 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T8 152-156 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T14 8-13 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T15 22-34 Chemical denotes antimalarial http://purl.obolibrary.org/obo/CHEBI_38068
T16 36-46 Chemical denotes antibiotic http://purl.obolibrary.org/obo/CHEBI_33281
T17 70-93 Chemical denotes HIV-protease inhibitors http://purl.obolibrary.org/obo/CHEBI_35660
T18 74-93 Chemical denotes protease inhibitors http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T20 83-93 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
17 184-192 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 0-193 Sentence denotes Several drugs such as antimalarial, antibiotic, anti-inflammatory and HIV-protease inhibitors are currently undergoing treatment as clinical studies to test the efficacy and safety of COVID-19.